兰地洛尔用于心脏手术后房颤的管理。
Landiolol for managing atrial fibrillation in post-cardiac surgery.
作者信息
Fellahi Jean-Luc, Heringlake Matthias, Knotzer Johann, Fornier William, Cazenave Laure, Guarracino Fabio
机构信息
Service d'Anesthésie-Réanimation, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 59 Boulevard Pinel, Lyon Cedex 03, France.
Department of Anesthesiology and Intensive Care Medicine, University of Lübeck, Ratzeburger Allee 160, Lübeck, Germany.
出版信息
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A4-A9. doi: 10.1093/eurheartj/sux038. Epub 2018 Jan 8.
Abstract
Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of landiolol in that specific surgical setting.
摘要
兰地洛尔是一种静脉注射用超短效β受体阻滞剂，在日本已使用多年，用于预防和/或治疗心脏手术后的房颤。该药物目前在欧洲也已上市。本文是关于兰地洛尔在特定手术环境中应用的文献系统综述。
相似文献
1
Landiolol for managing atrial fibrillation in post-cardiac surgery.
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A4-A9. doi: 10.1093/eurheartj/sux038. Epub 2018 Jan 8.
2
Landiolol for managing post-operative atrial fibrillation.
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A10-A14. doi: 10.1093/eurheartj/sux036. Epub 2018 Jan 8.
3
Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
J Thorac Cardiovasc Surg. 2015 Oct;150(4):957-64. doi: 10.1016/j.jtcvs.2015.07.003. Epub 2015 Jul 10.
4
[Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?].
Kyobu Geka. 2010 Mar;63(3):188-91.
5
Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation.
ESC Heart Fail. 2020 Oct;7(5):2208-2213. doi: 10.1002/ehf2.12879. Epub 2020 Jul 14.
6
Short acting intravenous beta-blocker as a first line of treatment for atrial fibrillation after cardiac surgery: a prospective observational study.
Eur Heart J Suppl. 2022 Jun 13;24(Suppl D):D34-D42. doi: 10.1093/eurheartjsupp/suac025. eCollection 2022 Jun.
7
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
J Clin Pharm Ther. 2012 Aug;37(4):431-5. doi: 10.1111/j.1365-2710.2011.01315.x. Epub 2011 Nov 7.
8
Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial.
Trials. 2023 May 25;24(1):353. doi: 10.1186/s13063-023-07353-6.
9
A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
J Cardiol. 2019 Nov;74(5):418-425. doi: 10.1016/j.jjcc.2019.05.012. Epub 2019 Jun 26.
10
An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation.
Pharmaceutics. 2024 Apr 8;16(4):517. doi: 10.3390/pharmaceutics16040517.
引用本文的文献
1
Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review.
J Clin Med. 2024 May 17;13(10):2951. doi: 10.3390/jcm13102951.
2
An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation.
Pharmaceutics. 2024 Apr 8;16(4):517. doi: 10.3390/pharmaceutics16040517.
3
Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial.
Trials. 2023 May 25;24(1):353. doi: 10.1186/s13063-023-07353-6.
4
Commentary: An ounce of prevention may not be worth a pound of cure-in postoperative atrial fibrillation.
JTCVS Open. 2020 Aug 8;3:86-87. doi: 10.1016/j.xjon.2020.08.005. eCollection 2020 Sep.
5
Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting.
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A1-A3. doi: 10.1093/eurheartj/sux037. Epub 2018 Jan 8.
6
Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction.
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A19-A24. doi: 10.1093/eurheartj/sux035. Epub 2018 Jan 8.
本文引用的文献
1
Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting.
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A1-A3. doi: 10.1093/eurheartj/sux037. Epub 2018 Jan 8.
2
Landiolol for managing post-operative atrial fibrillation.
Eur Heart J Suppl. 2018 Jan;20(Suppl A):A10-A14. doi: 10.1093/eurheartj/sux036. Epub 2018 Jan 8.
3
Prevention of atrial fibrillation after cardiac surgery using low-dose landiolol: A systematic review and meta-analysis.
J Clin Anesth. 2017 Nov;42:1-6. doi: 10.1016/j.jclinane.2017.07.009. Epub 2017 Jul 21.
4
Prognostic factors of atrial fibrillation following coronary artery bypass graft surgery.
Gen Thorac Cardiovasc Surg. 2017 Oct;65(10):566-574. doi: 10.1007/s11748-017-0797-6. Epub 2017 Jun 24.
5
Factors influencing postoperative atrial fibrillation in patients undergoing on-pump coronary artery bypass grafting, single center experience.
J Cardiothorac Surg. 2017 May 23;12(1):40. doi: 10.1186/s13019-017-0609-1.
6
Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention.
J Atr Fibrillation. 2013 Apr 6;5(6):781. doi: 10.4022/jafib.781. eCollection 2013 Apr-May.
7
Atrial fibrillation following aortic valve replacement: impact of perioperative use of intravenous β-blocker.
Gen Thorac Cardiovasc Surg. 2017 Apr;65(4):194-199. doi: 10.1007/s11748-016-0738-9. Epub 2016 Dec 20.
8
Rhythm is a dancer: the immediate management of postoperative atrial fibrillation following cardiac surgery.
Ann Transl Med. 2016 Oct;4(Suppl 1):S32. doi: 10.21037/atm.2016.09.43.
9
Increasing Occurrence of Postoperative Atrial Fibrillation in Contemporary Cardiac Surgery.
J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1302-7. doi: 10.1053/j.jvca.2016.02.013. Epub 2016 Feb 12.
10
The role of age and comorbidities in postoperative outcome of mitral valve repair: A propensity-matched study.
Medicine (Baltimore). 2016 Jun;95(25):e3938. doi: 10.1097/MD.0000000000003938.
Zotero 插件